These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18379871)

  • 1. Cyclin D1 immunoreactivity in meningiomas.
    Milenković S; Marinkovic T; Jovanovic MB; Djuricic S; Berisavac II; Berisavac I
    Cell Mol Neurobiol; 2008 Sep; 28(6):907-13. PubMed ID: 18379871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PCNA, Ki-67 and hTERT in residual benign meningiomas.
    Maes L; Kalala JP; Cornelissen M; De Ridder L
    In Vivo; 2006; 20(2):271-5. PubMed ID: 16634530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of cell adhesion proteins and proteins related to angiogenesis and fatty acid metabolism in benign, atypical, and anaplastic meningiomas.
    Panagopoulos AT; Lancellotti CL; Veiga JC; de Aguiar PH; Colquhoun A
    J Neurooncol; 2008 Aug; 89(1):73-87. PubMed ID: 18418552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of cyclin D1 expression in meningiomas: a preliminary study.
    Alama A; Barbieri F; Spaziante R; Bruzzo C; Dadati P; Dorcaratto A; Ravetti JL
    J Clin Neurosci; 2007 Apr; 14(4):355-8. PubMed ID: 17240151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA topoisomerase II-alpha and cyclin A immunoexpression in meningiomas and its prognostic significance: an analysis of 263 cases.
    Korshunov A; Shishkina L; Golanov A
    Arch Pathol Lab Med; 2002 Sep; 126(9):1079-86. PubMed ID: 12204057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ki-67 index as a predictive marker of meningioma recurrence following surgical resection.
    Mizrachi M; Hartley B; Saleem S; Hintz E; Ziemba Y; Li J; Goenka A; Schulder M
    J Clin Neurosci; 2024 Jun; 124():15-19. PubMed ID: 38631196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of COX-2 and VEGF expression in histopathologic grading and invasiveness of meningiomas.
    Lee SH; Lee YS; Hong YG; Kang CS
    APMIS; 2014 Jan; 122(1):16-24. PubMed ID: 23756256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA topoisomerase IIalpha expression correlates with cell proliferation but not with recurrence in intracranial meningiomas.
    Konstantinidou AE; Patsouris E; Korkolopoulou P; Kavantzas N; Mahera H; Davaris P
    Histopathology; 2001 Oct; 39(4):402-8. PubMed ID: 11683942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of p63 immunoreactivity with tumor grade in meningiomas.
    Rushing EJ; Olsen C; Man YG
    Int J Surg Pathol; 2008 Jan; 16(1):38-42. PubMed ID: 18203782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Proliferative markers of meningiomas: immunohistochemical analysis and prognostic value].
    Korshunov AG; Shishkina LV; Golanov AV
    Arkh Patol; 2002; 64(1):29-33. PubMed ID: 11889696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of tumor proliferation marker ki-67 and PCNA in surgical pathology].
    Su J; Zheng J
    Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):568-71. PubMed ID: 20021977
    [No Abstract]   [Full Text] [Related]  

  • 12. Growth rate of intracranial meningioma: tumor doubling time and proliferating cell nuclear antigen staining index.
    Ide M; Jimbo M; Yamamoto M; Umebara Y; Hagiwara S; Kubo O
    Neurol Med Chir (Tokyo); 1995 May; 35(5):289-93. PubMed ID: 7623949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proliferation markers, proliferating cell nuclear antigen, Ki67, 5-bromo-2'-deoxyuridine, and cyclin D1 in mouse olfactory epithelium.
    Ohta Y; Ichimura K
    Ann Otol Rhinol Laryngol; 2000 Nov; 109(11):1046-8. PubMed ID: 11089996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of androgen receptor in meningiomas.
    Chen J; Chen G
    J Tongji Med Univ; 2001; 21(2):140-2. PubMed ID: 11523220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sstr2A immunohistochemical expression in human meningiomas: is there a correlation with the histological grade, proliferation or microvessel density?
    Barresi V; Alafaci C; Salpietro F; Tuccari G
    Oncol Rep; 2008 Sep; 20(3):485-92. PubMed ID: 18695896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical expression of SPARC is correlated with recurrence, survival and malignant potential in meningiomas.
    Bozkurt SU; Ayan E; Bolukbasi F; Elmaci I; Pamir N; Sav A
    APMIS; 2009 Sep; 117(9):651-9. PubMed ID: 19703125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitosin, a novel marker of cell proliferation and early recurrence in intracranial meningiomas.
    Konstantinidou AE; Korkolopoulou P; Kavantzas N; Mahera H; Thymara I; Kotsiakis X; Perdiki M; Patsouris E; Davaris P
    Histol Histopathol; 2003 Jan; 18(1):67-74. PubMed ID: 12507285
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inverse correlation of cell proliferation and expression of progesterone receptors in tumor spheroids and monolayer cultures of human meningiomas.
    Tonn JC; Ott MM; Bouterfa H; Kerkau S; Kapp M; Müller-Hermelink HK; Roosen K
    Neurosurgery; 1997 Nov; 41(5):1152-9. PubMed ID: 9361071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of progestrone receptor and proliferative marker ki 67 in various grades of meningioma.
    Shayanfar N; Mashayekh M; Mohammadpour M
    Acta Med Iran; 2010; 48(3):142-7. PubMed ID: 21137648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.